159 related articles for article (PubMed ID: 31010436)
1. Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases.
Xu J; Chen Z; Wang Y; Wang X; Chen L; Yuan T; Tang X; Lu Y; Chen H; Chen M; Duan Z; Fan J; Liang J; Zhang X
Lipids Health Dis; 2019 Apr; 18(1):104. PubMed ID: 31010436
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
4. Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations.
Vegter EL; Ovchinnikova ES; van Veldhuisen DJ; Jaarsma T; Berezikov E; van der Meer P; Voors AA
Clin Res Cardiol; 2017 Aug; 106(8):598-609. PubMed ID: 28293796
[TBL] [Abstract][Full Text] [Related]
5. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
Abu-Halima M; Meese E; Keller A; Abdul-Khaliq H; Rädle-Hurst T
J Transl Med; 2017 Jul; 15(1):156. PubMed ID: 28693530
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as Novel Biomarkers for Atherosclerosis.
Yilmaz SG; Isbir S; Kunt AT; Isbir T
In Vivo; 2018; 32(3):561-565. PubMed ID: 29695561
[TBL] [Abstract][Full Text] [Related]
7. Characterization of micro-RNA Profile in the Blood of Patients with Marfan's Syndrome.
Abu-Halima M; Ludwig N; Rädle-Hurst T; Keller A; Motsch L; Marsollek I; El Rahman MA; Abdul-Khaliq H; Meese E
Thorac Cardiovasc Surg; 2018 Jan; 66(1):116-124. PubMed ID: 28679133
[TBL] [Abstract][Full Text] [Related]
8. Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients.
Maneerat Y; Prasongsukarn K; Benjathummarak S; Dechkhajorn W; Chaisri U
Lipids Health Dis; 2016 Jul; 15():117. PubMed ID: 27430968
[TBL] [Abstract][Full Text] [Related]
9. Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes.
Dostalova Merkerova M; Hrustincova A; Krejcik Z; Votavova H; Ratajova E; Cermak J; Belickova M
Neoplasma; 2017; 64(4):571-578. PubMed ID: 28485163
[TBL] [Abstract][Full Text] [Related]
10. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNAs as biomarkers for severe acute pancreatitis associated with acute lung injury.
Lu XG; Kang X; Zhan LB; Kang LM; Fan ZW; Bai LZ
World J Gastroenterol; 2017 Nov; 23(41):7440-7449. PubMed ID: 29151698
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive microRNA profiling reveals potential augmentation of the IL1 pathway in rheumatic heart valve disease.
Lu Q; Sun Y; Duan Y; Li B; Xia J; Yu S; Zhang G
BMC Cardiovasc Disord; 2018 Mar; 18(1):53. PubMed ID: 29548280
[TBL] [Abstract][Full Text] [Related]
14. Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.
Sun Y; Wang X; Wang Z; Zhang Y; Che N; Luo X; Tan Z; Sun X; Li X; Yang K; Wang G; Luan L; Liu Y; Zheng X; Wei M; Cheng H; Yin J
Epilepsy Res; 2016 Nov; 127():276-283. PubMed ID: 27689807
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Expression of Some Circulating miRNAs in Childhood Acute Lymphoblastic Leukemia.
Swellam M; Hashim M; Mahmoud MS; Ramadan A; Hassan NM
Biochem Genet; 2018 Aug; 56(4):283-294. PubMed ID: 29460192
[TBL] [Abstract][Full Text] [Related]
17. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
[TBL] [Abstract][Full Text] [Related]
18. Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling.
Ding M; Wang C; Lu X; Zhang C; Zhou Z; Chen X; Zhang CY; Zen K; Zhang C
Anal Bioanal Chem; 2018 Jun; 410(16):3805-3814. PubMed ID: 29671027
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
20. The involvement of circulating miR-146a and miR-27a in patients with atherosclerotic cardiovascular disease after SARS-CoV-2 infection.
Zhou J; Wei C; Li G; He W; Song M; Liu X; Feng J; Liu J
Clin Cardiol; 2024 Jun; 47(6):e24274. PubMed ID: 38884329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
